drugset / Trial / NCT03284463

Safety and Efficacy of Glibenclamide Combined With Rt-PA in Acute Cerebral Embolism

NCT03284463

Phase 2/3 Completed 306 enrolled Nanfang Hospital, Southern Medical University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is designed to evaluate the safety and efficacy of oral glibenclamide in acute ischemic stroke patients who under intravenous rt-PA thrombolysis.

Timeline

Start
2018-01-01
Primary completion
2022-08-28
Completion
2023-05-28

Drugs

EvaluationDrugModalityDoseRoute
Comparator Glyburide Small molecule 0.625 mg Oral

Indications